In the all-too-common debate over building lab facilities versus outsourcing, the best strategy may be the middle ground: licensing.
Ravi Samavedam
Advertisement
Ravi Samavedam is chief innovation officer at Azzur Group.
Articles by Ravi Samavedam
Advertisement
Latest Updated Articles
Threading the Needle Between DIY and CDMOPublished: November 15th 2022 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
2
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
3
Global Study Confirms Survival Advantage of Mogamulizumab in Advanced Mycosis Fungoides and Sézary Syndrome
4
Behind the Headlines Episode 27: Unpacking Mega Deals and R&D Directions
5
